BioCentury
ARTICLE | Clinical News

Foradil formoterol fumarate: Began Phase II testing

November 1, 1999 8:00 AM UTC

SkyePharma plc (LSE:SKP; SKYE), London, U.K. Novartis Pharma AG, Basel, Switzerland Product: Foradil formoterol fumarate Business: Autoimmune/Inflammation Therapeutic category: Receptor agonist Targ...